Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Virology|November 13, 2010
Poxvirus interleukin-4 expression overcomes inherent resistance and vaccine-induced immunity: pathogenesis, prophylaxis, and antiviral therapyNanhai Chen, Clifford J Bellone, Jill Schriewer, et al.
Virology|June 4, 2014
Initial characterization of vaccinia virus B4 suggests a role in virus spreadKristin Burles, Chad R Irwin, Robyn-Lee Burton, et al.
Microbes and Infection|October 15, 2013
Investigations of TB vaccine-induced mucosal protection in miceAzra Blazevic, Christopher S Eickhoff, Jaime Stanley, et al.
Antiviral Research|November 25, 2006
Oral 1-O-octadecyl-2-O-benzyl-sn-glycero-3-cidofovir targets the lung and is effective against a lethal respiratory challenge with ectromelia virus in miceKarl Y Hostetler, James R Beadle, Julissa Trahan, et al.
Vaccine|November 9, 2010
VennVax, a DNA-prime, peptide-boost multi-T-cell epitope poxvirus vaccine, induces protective immunity against vaccinia infection by T cell response aloneLeonard Moise, R Mark Buller, Jill Schriewer, et al.
Virus Genes|October 1, 2013
Expression of a non-coding RNA in ectromelia virus is required for normal plaque formationDavid J Esteban, Chris Upton, Casey Bartow-McKenney, et al.
Vaccine|October 11, 2011
The attenuated NYCBH vaccinia virus deleted for the immune evasion gene, E3L, completely protects mice against heterologous challenge with ectromelia virusKaren L Denzler, Jill Schriewer, Scott Parker, et al.
Antiviral Research|August 17, 2014
Co-administration of the broad-spectrum antiviral, brincidofovir (CMX001), with smallpox vaccine does not compromise vaccine protection in mice challenged with ectromelia virusScott Parker, Ryan Crump, Scott Foster, et al.
Plos One|June 8, 2010
Multiple phosphatidylinositol 3-kinases regulate vaccinia virus morphogenesisShannon McNulty, William Bornmann, Jill Schriewer, et al.
Antiviral Research|October 6, 2009
Antiviral evaluation of octadecyloxyethyl esters of (S)-3-hydroxy-2-(phosphonomethoxy)propyl nucleosides against herpesviruses and orthopoxvirusesNadejda Valiaeva, Mark N Prichard, R Mark Buller, et al.
Pageof 4